Legal battles, patent acquisitions and R&D dominate in-pharmatechnologist.com’s round up of developments in drug delivery this week with news from MonoSol, Acacia and a US University team working on GSK’s Relenza.
When selecting a pharmaceutical formulation, the conventional
wisdom has been to manipulate a drug delivery platform to make it
compatible with a drug's properties, yet the opposite approach may
have several benefits if enough...
CyDex has won the first regulatory approval in Japan for a
pharmaceutical product using its Captisol drug delivery technology
designed to improve the delivery of insoluble and unstable active